Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
Actual shortage: | 212 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
To be discontinued: | 2 (1%) | |
Discontinued: | 297 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-AMIODARONE | 200MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110664 |
TEVA-AMITRIPTYLINE | 25MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42619 |
TEVA-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2021-05-27 | 2021-08-06 | 140033 |
TEVA-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2021-06-03 | 2022-01-07 | 140405 |
TEVA-AMITRIPTYLINE | 25MG | TABLET | Resolved | 2021-06-24 | 2022-01-07 | 141466 |
TEVA-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2017-03-14 | 2018-03-08 | 2427 |
TEVA-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2017-03-14 | 2017-05-23 | 2434 |
TEVA-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2017-03-14 | 2017-05-23 | 2437 |
TEVA-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2017-04-03 | 2018-03-08 | 5171 |
TEVA-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2020-07-16 | 2020-09-24 | 120503 |
TEVA-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2020-10-01 | 2020-10-24 | 125509 |
TEVA-AMLODIPINE | 5MG | TABLET | Resolved | 2020-05-01 | 2020-07-10 | 113794 |
TEVA-AMLODIPINE | 10MG | TABLET | Resolved | 2020-05-01 | 2020-07-10 | 113797 |
TEVA-AMLODIPINE | 10MG | TABLET | Resolved | 2020-05-08 | 2020-07-10 | 114442 |
TEVA-AMLODIPINE | 5MG | TABLET | Resolved | 2017-05-10 | 2018-03-13 | 9788 |
TEVA-AMLODIPINE | 5MG | TABLET | Resolved | 2017-05-10 | 2018-03-13 | 9791 |
TEVA-AMLODIPINE | 5MG | TABLET | Resolved | 2017-08-01 | 2018-03-13 | 17847 |
TEVA-AMLODIPINE | 10MG | TABLET | Resolved | 2017-08-01 | 2018-03-13 | 17850 |
TEVA-AMLODIPINE | 10MG | TABLET | Resolved | 2017-08-21 | 2018-03-13 | 19925 |
TEVA-AMPHETAMINE XR | 25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-02-17 | 2022-04-21 | 155134 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256146 |
TEVA-VALSARTAN | 80MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256149 |
TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256152 |
TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256155 |
TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |